FIGURE 8.
FGF18 overexpression inhibits ccRCC progression via the EMT process through PI3K/Akt signaling pathway. (A) GSEA was performed to identify pathways between FGF18 high expression ccRCC tissues and low expression ccRCC tissues. (B) EMT was involved in the FGF18 high expression group. (C) Western blotting analysis of protein expression of EMT and PI3K/Akt signal pathway in NC and FGF18 overexpressed 786-O cell. (D) Western blotting analysis of protein expression of EMT and PI3K/Akt signal pathway in NC and FGF18 overexpressed 769-P cell. (E) Western blotting analysis of protein expression of EMT and PI3K/Akt signal pathway in NC and FGF18 overexpressed 786-O cell xenograft mice model.